| Mary C Ammerman, PSYD | |
|
158 Zillicoa St, Asheville, NC 28801-1079 | |
| (828) 254-9494 | |
| (828) 254-0161 |
| Full Name | Mary C Ammerman |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 22 Years |
| Location | 158 Zillicoa St, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467558122 | NPI | - | NPPES |
| 046F6 | Other | NC | BCBS OF NC |
| 6000709 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2990 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Institute For Applied Neuroscience | 4183884760 | 3 |
News Archive
The Boston Globe as part of a series examined the amount of influence religious conservatives might have on grants administered by USAID, including HIV prevention grants for the President's Emergency Plan for AIDS Relief.
In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes - certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray.
In a recent review article published in the Science of The Total Environment journal, a group of Polish researchers discussed the different transmission routes of the severe acute respiratory coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19). In their work, the researchers focused on the extent of SARS-CoV-2 survival in the environment, particularly in sewages and contaminated surfaces.
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
› Verified 1 days ago
| Entity Name | Institute For Applied Neuroscience |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508141938 PECOS PAC ID: 4183884760 Enrollment ID: O20120320000572 |
News Archive
The Boston Globe as part of a series examined the amount of influence religious conservatives might have on grants administered by USAID, including HIV prevention grants for the President's Emergency Plan for AIDS Relief.
In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes - certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray.
In a recent review article published in the Science of The Total Environment journal, a group of Polish researchers discussed the different transmission routes of the severe acute respiratory coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19). In their work, the researchers focused on the extent of SARS-CoV-2 survival in the environment, particularly in sewages and contaminated surfaces.
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary C Ammerman, PSYD 158 Zillicoa St, Asheville, NC 28801-1079 Ph: (828) 254-9494 | Mary C Ammerman, PSYD 158 Zillicoa St, Asheville, NC 28801-1079 Ph: (828) 254-9494 |
News Archive
The Boston Globe as part of a series examined the amount of influence religious conservatives might have on grants administered by USAID, including HIV prevention grants for the President's Emergency Plan for AIDS Relief.
In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Generally studies do this with billing or treatment codes - certain codes should identify who does and does not have recurrent cancer. A recent study published in the journal Medical Care shows that the commonly used data determinants of recurrent cancer may be misidentifying patients and potentially leading researchers astray.
In a recent review article published in the Science of The Total Environment journal, a group of Polish researchers discussed the different transmission routes of the severe acute respiratory coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19). In their work, the researchers focused on the extent of SARS-CoV-2 survival in the environment, particularly in sewages and contaminated surfaces.
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter from NASDAQ on July 8, 2010, stating that a NASDAQ Hearings Panel granted the Company's request for an extension of time, as permitted under NASDAQ's Listing Rules, to regain compliance with the $2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Stock Market.
Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells' ability to avoid detection and destruction by the immune system.
› Verified 1 days ago
Dr. Emily C Gordon, PHD CLINICAL PSYCHOL Psychologist Medicare: Accepting Medicare Assignments Practice Location: 540 Aiken Rd, Asheville, NC 28804 Phone: 828-645-1539 | |
Karen Marcus, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 30 Clayton St, Asheville, NC 28801 Phone: 828-258-1700 | |
Elizabeth Sarah Conder, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1 Oak Plz, Suite 206, Asheville, NC 28801 Phone: 828-252-2501 Fax: 828-252-2701 | |
Dr. Christopher Sanmiguel, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Mental Health Clinic, Asheville, NC 28805 Phone: 828-299-2519 | |
Edward Richards Johnston Iii, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 Mcdowell St, Asheville, NC 28801 Phone: 828-412-3144 Fax: 828-782-3002 | |
Dr. Susan L Hill, ED.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 158 Zillicoa St, Asheville, NC 28801 Phone: 828-254-9494 Fax: 828-254-0161 | |
Dr. Daniel H Cogswell, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 158 Zillicoa Street, Asheville, NC 28801 Phone: 828-254-9494 Fax: 828-254-0161 |